T. Araki

Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under Parg Deficiency

K. Ashizawa, J. Itami, M. Masutani, 2020, Cancers.

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles

Y. Murakami, M. Masutani, H. Ogino, 2022, Cancers.

Rectal Paraganglioma

H. Kawasaki, K. Shigematsu, Kazuyuki Ohata, 2018, Internal medicine.

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract

Ken Kato, K. Nakao, H. Taniguchi, 2016, Anti-cancer drugs.

Amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.

Ken Kato, K. Nakao, H. Taniguchi, 2014 .

Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report

Shinichiro Kobayashi, K. Kanetaka, Y. Akazawa, 2024, General Thoracic and Cardiovascular Surgery Cases.